Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

COVID-19 vaccine associated myocarditis on short-axis 1.5T MRI images of a 19-year-old man who presented with chest pain three days following the second dose of an mRNA COVID-19 vaccine.

New cardiac MRI analysis offers updated insight into long-term impact of vaccine-related myocarditis

Months after their initial myocarditis diagnosis, late gadolinium enhancement (LGE) was observed in 62% of patients on follow-up cardiac MRI.

Carotid endarterectomy (CEA) is not associated with a significant reduction in the risk of dementia, according to a new analysis published in the European Journal of Vascular & Endovascular Surgery.[1] However, the study’s authors noted, it did still lead to considerable improvements in stroke risk.

Carotid endarterectomy does not reduce long-term dementia risk

However, researchers noted, there was still a clear improvement in stroke risk.

Regulatory roundup: FDA clears new solutions from Boston Scientific, CathVision, Franklin Mountain Medical

It has been a busy few weeks for the FDA, with plenty of big-name approvals and recalls making the news, but there have also been some other big announcements related to solutions receiving FDA clearance. 

Thumbnail

Real-world Watchman patients experiencing fewer complications after LAAO than seen in clinical trials

The study's authors compared findings from the PROTECT-AF and PREVAIL clinical trials with data from the NCDR LAAO Registry, focusing on short-term and long-term outcomes. 

interventional cardiology heart failure cleveland clinic

4 promising heart failure therapies interventional cardiologists should keep an eye on

The devices, currently being investigated by teams of heart specialists, could make a big impact in the years ahead. 

Brugada arrhythmogenic substrate that causes VT and sudden cardiac death. This study showed ablation of this substrate area could help prevent sudden cardiac arrest in these patients.

Epicardial ablation in Brugada syndrome reduces sudden cardiac death

A late-breaking study at Heart Rhythm 2022 found epicardial ablation in Brugada syndrome helped significantly reduce sudden cardiac arrest in these patients, increasing their survival.

New-look protocol boosts outcomes among AFib patients in the ER

A large proportion of patients with atrial fibrillation (AFib) end up in emergency rooms (ERs), but there are inherent issues with most hospital ERs handing off these patients to electrophysiologists for follow-up care.

Pulmonary vein isolation (PVI) using higher power energy ablation was found to be safe, more effective and was able to cut procedure time, but there was a signal of increased emboli.

High power vs. standard RF ablation leads to improved pulmonary vein isolation, shorter procedures

New research, presented at Heart Rhythm 2022, found a 96% percent freedom from reoccurrence of atrial fibrillation in patients treated with high power vs. standard power radiofrequency ablation.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.